drugset / Trial / NCT03311724
A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine the efficacy of tirzepatide in participants with type 2 diabetes.
Timeline
- Start
- 2017-10-19
- Primary completion
- 2018-04-24
- Completion
- 2018-04-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tirzepatide | Peptide | 12 mg | Subcutaneous |
| Subject | Tirzepatide | Peptide | 15 mg | Subcutaneous |